Veterinary Blog

Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates

Veterinary Cancer Society 2022 Annual Conference Recap

Rising Women in Veterinary Oncology

Dr. Gerry Post

FidoCure® at VCS Mid-Year 2022: Lapatinib to treat grade II and III pulmonary carcinomas carrying ERBB2 V659E mutation: preliminary data

Dr. Lucas Rodrigues

Webinars

Dr. Gerry Post,

The Internet

Dr. Nicola Mason,

B.Vet.Med, PhD, DACVIM (Internal Medicine)

Personalized Medicine: Because Not All Tumors Are Created Equally

Dr. Gerry Post,

The Internet

Dr. Carrie Jurney,

DVM, DACVIM (Neurology), President  of Not One More Vet

Mental Health in the Veterinary Community in the Age of COVID-19

Dr. Gerry Post,

The Internet

Dr Barbara Kitchell,

DVM, DACVIM (Oncology)

Repurposed (Human and Animal) Drugs Amidst the COVID-19 Pandemic

Get to know: Ben Toussant, Chief of Staff and Director of Strategic Operations, FidoCure®

Christina K. Lopes

Feb 26, 2023 • 3 min read

One Health Day: Scientific Advisory Board Recognition

Christina K. Lopes

Nov 2, 2022 • 3 min read

Foundational Reads

Veterinary Cancer Society 2022 Annual Conference Recap

Dr. Gerry Post

Oct 30, 2022 • 3 min read

Thrive Pet Healthcare and FidoCure® Announce An Expansive Pet Precision Health Partnership

Christina K. Lopes

Jul 19, 2022 • 3 min read

Press release

Get to Know: Chase Schwalbach, Chief Product Officer, FidoCure

Christina K. Lopes

Jun 10, 2022 • 4 min read

Get to Know: Michelle

Dr. Gerry Post

May 25, 2022 • 3 min read

People

World Veterinary Day Interview: Strengthening Veterinary Resilience

Dr. Gerry Post

Apr 29, 2022 • 8 min read

FidoCure® at VCS Mid-Year 2022: Lapatinib to treat grade II and III pulmonary carcinomas carrying ERBB2 V659E mutation: preliminary data

Dr. Lucas Rodrigues

Apr 29, 2022 • 3 min read

Rising Women in Veterinary Oncology

Dr. Gerry Post

Mar 30, 2022 • 13 min read

New Hope for TCC Patients

Dr. Dorothy Jackson Girimonte

Feb 23, 2022 • 6 min read

Recent articles

Get to know: Ben Toussant, Chief of Staff and Director of Strategic Operations, FidoCure®

Osteosarcoma Case Study: Jade

Jejunal Adenocarcinoma Case Study: Callie

One Health Day: Scientific Advisory Board Recognition

Topics

Veterinary Blog

Veterinary Cancer Society 2022 Annual Conference Recap

Rising Women in Veterinary Oncology

FidoCure® at VCS Mid-Year 2022: Lapatinib to treat grade II and III pulmonary carcinomas carrying ERBB2 V659E mutation: preliminary data

Webinars

Personalized Medicine: Because Not All Tumors Are Created Equally

Mental Health in the Veterinary Community in the Age of COVID-19

Repurposed (Human and Animal) Drugs Amidst the COVID-19 Pandemic

Get to know: Ben Toussant, Chief of Staff and Director of Strategic Operations, FidoCure®

One Health Day: Scientific Advisory Board Recognition

Veterinary Cancer Society 2022 Annual Conference Recap

Thrive Pet Healthcare and FidoCure® Announce An Expansive Pet Precision Health Partnership

Get to Know: Chase Schwalbach, Chief Product Officer, FidoCure

Get to Know: Michelle

World Veterinary Day Interview: Strengthening Veterinary Resilience

FidoCure® at VCS Mid-Year 2022: Lapatinib to treat grade II and III pulmonary carcinomas carrying ERBB2 V659E mutation: preliminary data

Rising Women in Veterinary Oncology

New Hope for TCC Patients

Discover more content...

Results

We're sorry!

Recent articles

Get to know: Ben Toussant, Chief of Staff and Director of Strategic Operations, FidoCure®

Osteosarcoma Case Study: Jade

Jejunal Adenocarcinoma Case Study: Callie

One Health Day: Scientific Advisory Board Recognition

Topics